Antimicrobial activity of cephamycins and β-lactam/β-lactamase inhibitors against ESBL-producing Escherichia coli and Klebsiella pneumoniae under standard and high bacterial inocula.

Zavicefta (ceftazidime/avibactam) - Pfizer, AbbVie

Zerbaxa (ceftolozane /tazobactam) - Merck (MSD)

imipenem/relebactam - Merck (MSD)

Exblifep (cefepime/enmetazobactam) - Allecra

http://www.ncbi.nlm.nih.gov/pubmed/40118976

Da Eun Lee; Ji Young Choi; Ki Tae Kwon; Kwan Soo Ko; So Hyun Jun; Yu Mi Wi

Mar 22, 2025